Health Catalyst to Participate in Upcoming Investor Conference

Rhea-AI Summary

Health Catalyst (Nasdaq: HCAT) announced that senior management will participate in the 2026 Wells Fargo Healthcare Conference in Boston on Wednesday, September 9, 2026 and Thursday, September 10, 2026. The company highlights its healthcare intelligence platform, AI-driven technology, and $2.8 billion in documented outcomes supporting health system performance improvement.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SALT LAKE CITY, Aug. 31, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, today announced that members of senior management will participate in the 2026 Wells Fargo Healthcare Conference, taking place in Boston, on Wednesday, September 9, 2026 and Thursday, September 10, 2026.

About Health Catalyst

Health Catalyst, Inc. (Nasdaq: HCAT) is a healthcare intelligence company designed to accelerate measurable improvement for health systems across cost, clinical, and consumer performance. Backed by deep domain expertise, proprietary AI-driven technology, and $2.8 billion in documented outcomes, Health Catalyst helps health systems move from data to confident, measurable action.

Health Catalyst Investor Relations Contact:
Stephanie St. Clair
Finance and Investor Relations, SVP
+1 (855)-309-6800
ir@healthcatalyst.com

Health Catalyst Media Contact
Kay Blazar
VP, PR
SVM PR & Marketing
Healthcatalyst@SVMPR.com

FAQ

When will Health Catalyst (HCAT) participate in the 2026 Wells Fargo Healthcare Conference?

Health Catalyst senior management will participate on September 9–10, 2026 in Boston. According to Health Catalyst, the company’s leaders will attend the 2026 Wells Fargo Healthcare Conference over these two days to engage with investors and industry stakeholders.

What is the purpose of Health Catalyst (HCAT) attending the 2026 Wells Fargo Healthcare Conference?

Health Catalyst is attending to have senior management participate in the 2026 Wells Fargo Healthcare Conference. According to Health Catalyst, this involvement provides an opportunity to discuss its healthcare intelligence platform and outcomes-focused capabilities with the investor community.

What does Health Catalyst (HCAT) do as a healthcare intelligence company?

Health Catalyst provides healthcare intelligence technology to improve cost, clinical, and consumer performance for health systems. According to Health Catalyst, it leverages deep domain expertise, proprietary AI-driven tools, and $2.8 billion in documented outcomes to help organizations turn data into measurable actions.

How much documented outcomes value has Health Catalyst (HCAT) reported?

Health Catalyst reports $2.8 billion in documented outcomes from its solutions. According to Health Catalyst, these outcomes reflect measurable improvements achieved by client health systems across cost, clinical, and consumer performance using its AI-driven healthcare intelligence platform.

Who is the investor relations contact for Health Catalyst (HCAT) around the 2026 conference?

The investor relations contact is Stephanie St. Clair, Finance and Investor Relations SVP. According to Health Catalyst, investors can reach her at +1 (855)-309-6800 or by email at ir@healthcatalyst.com for questions related to the company and its conference participation.

Who should media contact regarding Health Catalyst (HCAT) and the 2026 Wells Fargo Healthcare Conference?

Media inquiries should be directed to Kay Blazar, VP, PR at SVM PR & Marketing. According to Health Catalyst, media can contact her via email at Healthcatalyst@SVMPR.com for information about the company and its conference presence.